Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

被引：52

作者：

Wells, SA

Skinner, MA

机构：

[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA

[2] Washington Univ, Sch Med, Div Pediat Surg, St Louis, MO 63130 USA

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 1998年 / 106卷 / 01期

关键词：

multiple endocrine neoplasia; medullary thyroid carcinoma; childhood cancer;

D O I：

10.1055/s-0029-1211946

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since the discovery that germ-line mutations in the RET protooncogene are responsible for the multiple endocrine neoplasia (MEN) syndromes types 2A and 2B, prophylactic thyroidectomy has been recommended for MEN patients to prevent medullary thyroid carcinoma (MTC). In this report, we present the medium-term follow up results on the earliest group of 18 patients having prophylactic thyroidectomy for MEN 2A. There were no operative complications. Microscopic or grossly evident MTC was present in 14 (78%) of the resected patients. None of the patients had metastasis of their MTC to regional lymph nodes. At three years' follow up, there is no evidence of residual or recurrent MTC, based on biochemical testing. We conclude that prophylactic thyroidectomy, based on direct DNA testing for RET gene mutations, is an effective and safe way to manage MTC in patients with MEN 2A.

引用

页码：29 / 34

页数：6

共 16 条

[1]

CARLSON KM, 1994, HUM MOL GENET, V3, P1207

[2] Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].

Chandrasekharappa, SC ;

Guru, SC ;

Manickam, P ;

Olufemi, SE ;

Collins, FS ;

EmmertBuck, MR ;

Debelenko, LV ;

Zhuang, ZP ;

Lubensky, IA ;

Liotta, LA ;

Crabtree, JS ;

Wang, YP ;

Roe, BA ;

Weisemann, J ;

Boguski, MS ;

Agarwal, SK ;

Kester, MB ;

Kim, YS ;

Heppner, C ;

Dong, QH ;

Spiegel, AM ;

Burns, AL ;

Marx, SJ .

SCIENCE, 1997, 276 (5311) :404-407

[3]

CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO

[4]

2-W

[5] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].

DONISKELLER, H ;

DOU, SS ;

CHI, D ;

CARLSON, KM ;

TOSHIMA, K ;

LAIRMORE, TC ;

HOWE, JR ;

MOLEY, JF ;

GOODFELLOW, P ;

WELLS, SA .

HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856

[6] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].

Eng, C ;

Clayton, D ;

Schuffenecker, I ;

Lenoir, G ;

Cote, G ;

Gagel, RF ;

vanAmstel, HKP ;

Lips, CJM ;

Nishisho, I ;

Takai, SI ;

Marsh, DJ ;

Robinson, BG ;

FrankRaue, K ;

Raue, F ;

Xue, FY ;

Noll, WW ;

Romei, C ;

Pacini, F ;

Fink, M ;

Niederle, B ;

Zedenius, J ;

Nordenskjold, M ;

Komminoth, P ;

Hendy, GN ;

Gharib, H ;

Thibodeau, SN ;

Lacroix, A ;

Frilling, A ;

Ponder, BAJ ;

Mulligan, LM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579

[7] FAMILIAL MEDULLARY-THYROID CARCINOMA WITHOUT ASSOCIATED ENDOCRINOPATHIES - A DISTINCT CLINICAL ENTITY [J].

FARNDON, JR ;

LEIGHT, GS ;

DILLEY, WG ;

BAYLIN, SB ;

SMALLRIDGE, RC ;

HARRISON, TS ;

WELLS, SA .

BRITISH JOURNAL OF SURGERY, 1986, 73 (04) :278-281

[8] SYNDROME OF EXCESSIVE THYROCALCITONIN PRODUCED BY MEDULLARY CARCINOMA OF THYROID [J].

MELVIN, KEW ;

TASHJIAN, AH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1968, 59 (04) :1216-&

[9]

MENDELSOHN G, 1988, DIAGNOSIS PATHOLOGY, P93

[10]

MILHAUD G, 1968, CR ACAD SCI D NAT, V266, P608

← 1 2 →